from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3015c/-

LFCtreatmentdescriptionclass of inhibitor

0.390

Amikacinug/mL Amikacintranslation

-0.719

Cap5-10ug/mL Capreomycintranslation

-1.230

Rox10-50 ug/mL Roxithromycintranslation

-0.274

SM2-5 ug/mL Streptomycintranslation

-0.676

Tet5-10 ug/mL Tetracyclinetranslation

2.172

Rif0.2-5ug/mL Rifampicintranscription

0.397

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.698

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.092

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.765

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.469

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.954

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.500

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.627

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.484

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.542

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.621

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.364

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.207

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.626

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.874

KCN5-20 ug/mL Potassium cyaniderespiration

-0.252

NaN30.2-2 mM Sodium aziderespiration

-1.212

Nigericin50 uM Nigericinrespiration

0.086

TRC10-150 ug/mL Triclosanrespiration

-0.685

TRZ10-25 ug/mL Thioridazinerespiration

-1.819

Valinomycin0.5-10 uM Valinomycinrespiration

-0.512

ZnSO42 mM ZnSO4respiration

-0.934

menadione6-10 ug/mL Menadionerespiration

0.389

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.270

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.637

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-1.023

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.544

NRP_1Non-replicating persistence stage 1dosRassociated

-0.167

Amp0.2mg/mL AmpicillincellWall

-0.097

Cephalexin20-100 ug/mL CephalexincellWall

0.252

Cerulenin0.32-5 ug/mL CerulenincellWall

1.769

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.621

EMB10-20 ug/mL EthambutolcellWall

-0.446

Eta12-40 ug/mL EthionamidecellWall

-0.628

INH0.2-0.4 ug/mL IsoniazidcellWall

0.314

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.620

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.000

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.605

BZA0.12 mg/mL BenzamidearomaticAmides

0.762

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.032

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

1.052

H2O24 mM hydrogen peroxideDNAdamaging

-0.236

Levo10 ug/mL LevofloxacinDNAdamaging

0.613

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.848

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.421

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.697

UVUV-irradiationDNAdamaging

-0.005

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.426

Antimycin12.5-50 ug/mL Antimycin A?

-1.031

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.285

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.268

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.919

PA8240.2-2 ug/mL PA-824?

-0.293

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.022

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.136

Verapamil50 uM Verapamil?

-1.060

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.566

methoxatin10-20 ug/mL Methoxatin?